These defects are associated with a shift in the balance of interleukin (IL)-17 and IFN-γ responses, and failure of activated T cells to express the co-stimulatory molecule CD154 showing that circulating CD4 T cells already show high degrees of immune dysfunction. The gene discussed is CD40LG; the disease is immune system disorder.